NEW YORK (360Dx) – Qiagen said on Thursday that Japan's Ministry of Health, Labor and Welfare has approved QuantiFeron-TB Gold Plus (QFT-Plus) as an in vitro diagnostic to detect tuberculosis infection.

QFT-Plus is the fourth generation of Qiagen's QuantiFeron-TB technology, combining CD4+/CD8+ design for comprehensive immune response detection with a flexible blood collection workflow for efficient screening in large-scale TB control programs, Qiagen said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.